Table 1.

Autoimmune gastritis: mode of presentation, associated findings, and results of endoscopy




Macrocytic, n = 29

Normocytic, n = 48

Microcytic, n = 83
Age, y, ± SD (M/F)   62 ± 15 (17/12)   58 ± 17 (18/30)   41 ± 15 (18/65)  
Anemic, no. (%)   18 (62)   19 (40)   83 (100)  
Low B12 level, no. (%)   29 (100)   44 (92)   38 (46)  
Iron deficiency, no. (%)   3 (10)   24 (50)   83 (100)  
Thyroid disease, no. (%)  3 (10)   14 (29)   15 (18)  
   Hypothyroid, no.   3   12   12  
   Graves disease, no.   0   1   2  
   Hashimoto thyroiditis, no.   0   1   1  
Vitiligo, no. (%)   2 (7)   0 (0)   0 (0)  
Diabetes mellitus, no. (%)   1 (3)   4 (8)   7 (8)  
Neurologic complications, no. (%)   5 (17)   2 (4)   0 (0)  
Gastric histology, total no.  13   24   32  
   Atrophic gastritis, no. (%)   9 (69)   13 (54)   13 (41)  
   Chronic gastritis, no. (%)   2 (15)   9 (38)   18 (56)  
   MALT lymphoma, no. (%)   1 (8)   1 (4)   0 (0)  
   Neoplasia, no., type (%)
 
1, adenocarcinoma (8)
 
1, polyp (4)
 
1, polyp (3)
 



Macrocytic, n = 29

Normocytic, n = 48

Microcytic, n = 83
Age, y, ± SD (M/F)   62 ± 15 (17/12)   58 ± 17 (18/30)   41 ± 15 (18/65)  
Anemic, no. (%)   18 (62)   19 (40)   83 (100)  
Low B12 level, no. (%)   29 (100)   44 (92)   38 (46)  
Iron deficiency, no. (%)   3 (10)   24 (50)   83 (100)  
Thyroid disease, no. (%)  3 (10)   14 (29)   15 (18)  
   Hypothyroid, no.   3   12   12  
   Graves disease, no.   0   1   2  
   Hashimoto thyroiditis, no.   0   1   1  
Vitiligo, no. (%)   2 (7)   0 (0)   0 (0)  
Diabetes mellitus, no. (%)   1 (3)   4 (8)   7 (8)  
Neurologic complications, no. (%)   5 (17)   2 (4)   0 (0)  
Gastric histology, total no.  13   24   32  
   Atrophic gastritis, no. (%)   9 (69)   13 (54)   13 (41)  
   Chronic gastritis, no. (%)   2 (15)   9 (38)   18 (56)  
   MALT lymphoma, no. (%)   1 (8)   1 (4)   0 (0)  
   Neoplasia, no., type (%)
 
1, adenocarcinoma (8)
 
1, polyp (4)
 
1, polyp (3)
 
Close Modal

or Create an Account

Close Modal
Close Modal